# clm_65C9343FBB71

subject: Regeneron Pharmaceuticals (/record/regeneron-pharmaceuticals.md)  
predicate: net_income  
value: 636,056,000 United States dollar  
valid_from: 2015-12-31  
valid_to: 2016-12-31  
published: 2016-02-11  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_AFF68BBC35BE  
last_updated: 2026-11-08  
cite: AsOf. "Regeneron Pharmaceuticals net income: 636,056,000 United States dollar", as of 2015-12-31 (until 2016-12-31). Claim clm_65C9343FBB71, https://asof.is/claim/clm_65C9343FBB71, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/872589/000153217616000045/0001532176-16-000045-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:NetIncomeLoss in 10-K FY2015, filed 2016-02-11  

## Sources

- https://www.sec.gov/Archives/edgar/data/872589/000153217616000045/0001532176-16-000045-index.htm (primary, SEC EDGAR 10-K FY2015, published 2016-02-11)

## Supersedes

- [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | net_income | 348,074,000 United States dollar | valid 2014-12-31 to 2015-12-31 | conf 0.95 | superseded | superseded_by [clm_65C9343FBB71](/claim/clm_65C9343FBB71.md) | [clm_D3F5BB8C7757](/claim/clm_D3F5BB8C7757.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.